Behavioral
Carthage Area Hospital INC
Carthage Area Hospital INC was paid $9.61M by Medicaid between Jan 2018 and Nov 2024, across 175 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 19% of everything it billed.
33Billing provider infoCARTHAGE AREA HOSPITAL INC
CARTHAGE, NY 13619
CARTHAGE, NY 13619
33aNPI1053497388assigned 10/30/2006
33bProvider typeSocial Worker
28Total paid$9.61M
24GClaims143,498
24DCodes billed175
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Social Worker providers in New York
Rank by total paid#7 of 192
Median peer was paid$40K
This provider vs. median243×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,077 | $200K | |
| 2019 | 20,482 | $1.03M | |
| 2020 | 48,302 | $2.53M | |
| 2021 | 20,068 | $982K | |
| 2022 | 21,216 | $2.94M | |
| 2023 | 16,592 | $1.32M | |
| 2024incomplete | 12,761 | $617K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 18,323 | 16,737 | $1.79M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 11% | 5,220 | 3,703 | $1.09M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 6.5% | 4,801 | 4,660 | $622K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 5.9% | 3,302 | 2,503 | $571K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 5.8% | 4,908 | 4,733 | $553K |
| 36415 | Collection of venous blood by venipuncture | 4.9% | 7,551 | 6,645 | $475K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.4% | 3,619 | 3,437 | $426K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.3% | 2,527 | 2,436 | $412K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4.1% | 1,812 | 1,604 | $392K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.7% | 2,054 | 1,898 | $258K |
| 41899 | Unlisted procedure, dentoalveolar structures | 2.2% | 215 | 215 | $208K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.8% | 1,863 | 1,733 | $178K |
163 more codes
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.7% | 1,296 | $165K |
| 99203 | Doctor's office visit, new patient (routine) | 1.7% | 1,025 | $162K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.5% | 1,317 | $147K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.5% | 1,033 | $146K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.5% | 2,508 | $146K |
| 80053 | Comprehensive metabolic panel | 1.4% | 6,722 | $136K |
| 90791 | Psychiatric diagnostic evaluation | 1.4% | 678 | $134K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.4% | 794 | $133K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.2% | 865 | $111K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.1% | 1,513 | $105K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.1% | 363 | $104K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,604 | $74K |
| 92551 | <1% | 661 | $72K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 232 | $69K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,410 | $68K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,906 | $66K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 190 | $58K |
| 90837 | Psychotherapy session, about an hour | <1% | 269 | $48K |
| 81025 | <1% | 877 | $45K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 859 | $37K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 348 | $36K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 262 | $31K |
| 90686 | <1% | 1,241 | $30K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 334 | $29K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 110 | $24K |
| 96160 | <1% | 430 | $23K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 679 | $22K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,218 | $21K |
| 99000 | <1% | 718 | $20K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 579 | $19K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 137 | $19K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 557 | $19K |
| 80061 | Lipid panel | <1% | 2,196 | $18K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,991 | $17K |
| 99173 | <1% | 324 | $17K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 855 | $17K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 131 | $15K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 2,211 | $15K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 51 | $13K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 55 | $13K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,901 | $12K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,101 | $11K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 77 | $9K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 882 | $8K |
| 90670 | <1% | 402 | $8K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 177 | $8K |
| 84439 | <1% | 1,234 | $8K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,225 | $8K |
| 83880 | <1% | 239 | $7K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,157 | $7K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 59 | $6K |
| 88142 | <1% | 214 | $6K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 54 | $6K |
| 90656 | <1% | 54 | $5K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 1,300 | $5K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 858 | $5K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 13 | $4K |
| 97161 | <1% | 44 | $4K | |
| 99402 | <1% | 77 | $4K | |
| 85027 | <1% | 1,421 | $3K | |
| 90633 | <1% | 130 | $3K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,156 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 199 | $3K |
| 90647 | <1% | 231 | $3K | |
| 90723 | <1% | 225 | $3K | |
| 90734 | <1% | 60 | $2K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 26 | $2K |
| 82607 | <1% | 277 | $2K | |
| 81015 | <1% | 2,898 | $2K | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 15 | $2K |
| 96367 | <1% | 17 | $2K | |
| 11056 | <1% | 50 | $2K | |
| 86141 | <1% | 320 | $2K | |
| 99442 | <1% | 27 | $1K | |
| 87486 | <1% | 52 | $1K | |
| 96127 | <1% | 258 | $1K | |
| 90715 | <1% | 59 | $1K | |
| 81002 | <1% | 1,020 | $1K | |
| 80361 | <1% | 127 | $1K | |
| 87581 | <1% | 52 | $1K | |
| 83735 | <1% | 593 | $995.71 | |
| 80373 | <1% | 83 | $903.63 | |
| 80354 | <1% | 83 | $819.99 | |
| 86850 | <1% | 64 | $799.11 | |
| 76801 | <1% | 12 | $767.15 | |
| 80372 | <1% | 83 | $766.98 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 213 | $765.15 |
| 85730 | <1% | 461 | $730.76 | |
| 82550 | <1% | 315 | $719.18 | |
| 87186 | <1% | 288 | $693.51 | |
| 81003 | <1% | 1,017 | $618.24 | |
| 90681 | <1% | 67 | $606.90 | |
| 82728 | <1% | 78 | $606.31 | |
| 87102 | <1% | 106 | $602.19 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 44 | $587.68 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 73 | $586.23 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 66 | $562.37 |
| 83655 | <1% | 45 | $558.71 | |
| 80324 | <1% | 126 | $552.66 | |
| 80365 | <1% | 126 | $540.65 | |
| 80076 | <1% | 54 | $494.80 | |
| 87081 | <1% | 124 | $494.64 | |
| 99001 | <1% | 64 | $483.46 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 255 | $483.00 |
| 80346 | <1% | 112 | $481.14 | |
| 80348 | <1% | 112 | $463.98 | |
| 82746 | <1% | 59 | $463.59 | |
| 85610 | <1% | 278 | $456.33 | |
| D1206 | Topical application of fluoride varnish | <1% | 15 | $454.50 |
| 80358 | <1% | 114 | $434.02 | |
| 80359 | <1% | 112 | $424.02 | |
| 80353 | <1% | 112 | $424.02 | |
| 85651 | <1% | 395 | $414.60 | |
| 90671 | <1% | 16 | $401.60 | |
| 80321 | <1% | 83 | $383.03 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 12 | $330.68 |
| 83690 | <1% | 1,828 | $328.16 | |
| 86376 | <1% | 29 | $321.77 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,207 | $321.67 |
| 86901 | <1% | 38 | $315.71 | |
| 84481 | <1% | 40 | $308.56 | |
| 84703 | <1% | 752 | $301.52 | |
| 84702 | <1% | 67 | $296.88 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 754 | $271.55 |
| 86780 | <1% | 28 | $268.29 | |
| 86900 | <1% | 38 | $264.62 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 966 | $250.50 |
| 84550 | <1% | 64 | $249.77 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 25 | $235.32 |
| 93000 | <1% | 196 | $226.34 | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 15 | $195.00 |
| 84484 | <1% | 819 | $170.46 | |
| 87340 | <1% | 13 | $126.37 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 18 | $113.22 |
| 86618 | <1% | 14 | $112.98 | |
| 83605 | <1% | 1,420 | $103.93 | |
| 85378 | <1% | 256 | $96.57 | |
| 86038 | <1% | 28 | $93.60 | |
| 83550 | <1% | 27 | $93.23 | |
| 74022 | <1% | 15 | $62.40 | |
| 73030 | <1% | 16 | $54.00 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 32 | $52.00 |
| 84436 | <1% | 12 | $34.20 | |
| 83540 | <1% | 12 | $30.18 | |
| 86308 | <1% | 16 | $29.40 | |
| 87040 | <1% | 222 | $24.45 | |
| 85018 | <1% | 13 | $22.00 | |
| 85014 | <1% | 13 | $22.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,125 | $20.06 |
| 87070 | <1% | 12 | $17.81 | |
| 71045 | Radiologic examination, chest; single view | <1% | 303 | $6.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 957 | $5.82 |
| 80320 | <1% | 28 | $5.00 | |
| 87210 | <1% | 12 | $3.40 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,142 | $2.67 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 627 | $1.10 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 527 | $1.06 |
| J2704 | Injection, propofol, 10 mg | <1% | 376 | $0.67 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 54 | $0.00 |
| 99070 | 0% | 12 | $0.00 | |
| 73630 | 0% | 13 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 12 | $0.00 |
| 81449 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDUVALL, RICHARD (CEO ADMINSTRATOR)
| Provider | Location | Paid |
|---|---|---|
| Carthage Area Hospital, INC. | Carthage, NY | $16.07M |
| Carthage Area Hospital INC. | Carthage, NY | $2.66M |
| Carthage Area Hospital, INC. | Carthage, NY | $669K |
| Carthage Area Hospital INC | Carthage, NY | $227K |
| Carthage Area Hospital INC | Carthage, NY | $221K |
| Carthage Area Hospital, INC. | Lafargeville, NY | $74K |
| Carthage Area Hospital INC | Beaver Falls, NY | $58K |
| Claxton-Hepburn Medical Center | Ogdensburg, NY | $24K |
| Carthage Area Hospital INC | Philadelphia, NY | $5K |
| Claxton-Hepburn Medical Center | Canton, NY | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.